Physician profile
Christopher L Marsh
NPI 1053412478
$838.40
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $261 · 2021: $290 · 2022: $17.86.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $171.85 | 2019-2020 | |
| Novo Nordisk INC | $102.82 | 2020-2021 | |
| Lilly USA, LLC | $73.13 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.29 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $38.30 | 2020 | |
| Amgen INC. | $37.74 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $36.78 | 2020-2021 | |
| Biolase, INC. | $36.75 | 2021 | |
| Amarin Pharma, INC. | $35.96 | 2021 | |
| Amneal Pharmaceuticals LLC | $32.65 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $30.35 | 2021 | |
| Glaxosmithkline, LLC. | $26.05 | 2019-2020 | |
| Esperion Therapeutics, INC. | $23.60 | 2020 | |
| Novartis Pharmaceuticals Corporation | $23.25 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.78 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18.42 | 2021 | |
| Abbvie INC. | $17.76 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.13 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.11 | 2019 | |
| Pfizer INC. | $10.86 | 2019 | |
| Supernus Pharmaceuticals, INC. | $10.82 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Marsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.